JPMorgan Chase & Co. lessened its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 8.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,757 shares of the medical instruments supplier’s stock after selling 3,151 shares during the quarter. JPMorgan Chase & Co. owned about 0.91% of Utah Medical Products worth $2,444,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Russell Investments Group Ltd. lifted its stake in shares of Utah Medical Products by 19.1% during the second quarter. Russell Investments Group Ltd. now owns 47,619 shares of the medical instruments supplier’s stock valued at $3,448,000 after acquiring an additional 7,649 shares during the period. Brandes Investment Partners LP acquired a new position in shares of Utah Medical Products during the second quarter valued at $2,833,000. Bessemer Group Inc. lifted its stake in shares of Utah Medical Products by 39.4% during the second quarter. Bessemer Group Inc. now owns 4,600 shares of the medical instruments supplier’s stock valued at $333,000 after acquiring an additional 1,300 shares during the period. Spark Investment Management LLC acquired a new position in shares of Utah Medical Products during the second quarter valued at $325,000. Finally, Cardinal Capital Management lifted its stake in shares of Utah Medical Products by 15.5% during the second quarter. Cardinal Capital Management now owns 9,180 shares of the medical instruments supplier’s stock valued at $665,000 after acquiring an additional 1,235 shares during the period. 66.77% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “JPMorgan Chase & Co. Cuts Stake in Utah Medical Products, Inc. (UTMD)” was published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.com-unik.info/2017/10/13/jpmorgan-chase-co-cuts-stake-in-utah-medical-products-inc-utmd.html.
Separately, BidaskClub raised Utah Medical Products from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, October 3rd. Investors of record on Friday, September 15th were given a dividend of $0.265 per share. The ex-dividend date of this dividend was Thursday, September 14th. This represents a $1.06 dividend on an annualized basis and a yield of 1.38%. Utah Medical Products’s dividend payout ratio is currently 30.37%.
About Utah Medical Products
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).
What are top analysts saying about Utah Medical Products Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Utah Medical Products Inc. and related companies.